Baxdrostat and Other Aldosterone Synthase Inhibitors for Uncontrolled Hypertension in CKD

Marieta P. TheodorakopoulouPantelis Sarafidis2026-03-222026-03-22202510.1681/asn.0000000978https://doi.org/10.1681/asn.0000000978https://andeanlibrary.org/handle/123456789/78991enMedicineInternal medicineEndocrinologyKidney diseaseAldosteroneAldosterone synthaseEnzyme inhibitorATP synthaseKidneyBaxdrostat and Other Aldosterone Synthase Inhibitors for Uncontrolled Hypertension in CKDarticle